A Prospective, Multicenter Study of the Glaukos® iStent Infinite Trabecular Micro-Bypass System Model iS3 in Subjects With Mild to Moderate Primary Open-angle Glaucoma
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
Eligibility
Participation Requirements
Sex: All
Minimum Age: 35
Healthy Volunteers: f
View:
• Diagnosis of primary open-angle glaucoma
• Phakic or pseudophakic
• Age 35 years or older
Locations
United States
Ohio
Glaukos Investigator Site
RECRUITING
Cincinnati
Contact Information
Primary
Dari Parizadeh
dparizadeh@glaukos.com
949-481-0575
Backup
Kerry Stephens
kstephens@glaukos.com
949-481-8057
Time Frame
Start Date: 2023-09-01
Estimated Completion Date: 2027-08
Participants
Target number of participants: 245
Treatments
Experimental: iStent Infinite
iStent Infinite Trabecular Micro-Bypass System
Related Therapeutic Areas
Sponsors
Leads: Glaukos Corporation